Sensory (nociceptive) stimulation evokes Fos expression in the subthalamus of hemiparkinsonian rats

Neurological Research

Volumn 30, Issue 3, 2008, Pages 277-284

  Heise, Claire E ^a   Reyes, Stefanie ^a   Mitrofanis, John ^a,b,c  

^a UNIVERSITY OF SYDNEY   (Australia)

^b The Australian National University   (Australia)

^c AUSTRALIAN NATIONAL UNIVERSITY   (Australia)

Author keywords

Basal ganglia; Cell activity; Parkinson's disease

Indexed keywords

5 HYDROXYDOPAMINE; PROTEIN FOS; SODIUM CHLORIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASAL GANGLION; CELL ACTIVITY; CONTROLLED STUDY; IMMUNOHISTOCHEMISTRY; MALE; MECHANICAL STIMULATION; MEDIAL FOREBRAIN BUNDLE; NIGRONEOSTRIATAL SYSTEM; NOCICEPTIVE STIMULATION; NONHUMAN; PARKINSONISM; PROTEIN EXPRESSION; RAT;

ANIMALS; CELL COUNT; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION; MALE; NEURONS; ONCOGENE PROTEINS V-FOS; OXIDOPAMINE; PAIN; PARKINSON DISEASE, SECONDARY; PHYSICAL STIMULATION; RATS; RATS, SPRAGUE-DAWLEY; SUBTHALAMUS; TYROSINE 3-MONOOXYGENASE;

EID: 44449142888     PISSN: 01616412     EISSN: None     Source Type: Journal    
DOI: 10.1179/016164107X235455     Document Type: Article

References (29)

1. Alegre M, Alonso-Frech F, Rodriguez-Oroz MC, et al. Movement-related changes in oscillatory activity in the human subthalamic nucleus: Ipsilateral vs. contralateral movements. Eur J Neurosci 2005; 22: 2315-2324
2. Aziz TZ, Peggs D, Sambrook MA, et al. Lesion of the subthalamic nucleus for the alleviation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced parkinsonism in the primate. Mov Disord 1991; 6: 288-292
3. Benabid AL, Benazzouz A, Pollack P. Mechanisms of deep brain stimulation. Mov Disord 2002; 17 (Suppl. 3): S73-S74
4. Benazzouz A, Gross C, Feger J, et al. Reversal of rigidity and improvement in motor performance by subthalamic high-frequency stimulation in MPTP-treated monkeys. Eur J Neurosci 1993; 5: 382-389
5. Benazzouz A, Piallat B, Pollak P, et al. Responses of substantia nigra pars reticulata and globus pallidus complex to high frequency stimulation of the subthalamic nucleus in rats: Electrophysiological data. Neurosci Lett 1995; 189: 77-80
6. Bergman H, Deuschl G. Pathophysiology of Parkinson's disease: From clinical neurology to basic neuroscience and back. Mov Disord 2002; 17 (Suppl. 3): S28-S40
7. Bezard E, Boraud T, Bioulac B. Gross, Involvement of the subthalamic nucleus in glutamatergic compensatory mechanisms. Eur J Neurosci 1999; 11: 2167-2170
8. Bullitt E. Induction of c-Fos-like protein within the lumbar spinal cord and thalamus of the rat following peripheral stimulation. Brain Res 1989; 493: 391-397
9. Bullitt E, Lee CL, Light AR, et al. The effect of stimulus duration on noxious-stimulus induced c-fos expression in the rodent spinal cord. Brain Res 1992; 580: 172-179
10. Djaldetti R, Shifrin A, Rogowski Z, et al. Quantitative measurement of pain sensation in patients with Parkinson disease. Neurology 2004; 62: 2171-2175
11. Heise CE, Teo ZC, Wallace BA, et al. Cell survival patterns in the pedunculopontine tegmental nucleus of methyl-4-phenyl-1,2,3,6- tetrahydropyridine-treated monkeys and 6OHDA-lesioned rats: Evidence for differences to idiopathic Parkinson disease patients? Anat Embryol (Berl) 2005; 210: 287-302
12. Hollerman JR, Grace AA. Subthalamic nucleus cell firing in the 6-OHDA-treated rat: Basal activity and response to haloperidol. Brain Res 1992; 590: 291-299
13. Hutchison WD, Allan RJ, Opitz H, et al. Neurophysiological identification of the subthalamic nucleus in surgery for Parkinson's disease. Ann Neurol 1998; 44: 622-628
14. Kaelber WW. Escape from and avoidance of nociception elicited by intracranial stimulation of the cat subthalamus. Exp Neurol 1981; 73: 397-420
15. Keay KA, Bandler R. Deep and superficial noxious stimulation increases Fos-like immunoreactivity in different regions of the midbrain periaqueductal grey of the rat. Neurosci Lett 1993; 154: 23-26
16. Mitchell IJ, Clarke CE, Boyce S, et al. Neural mechanisms underlying parkinsonian symptoms based on regional uptake of 2-deoxyglucose in monkeys exposed to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Neuroscience 1989; 32: 213-226
17. Miyakawa H, Okuda K, Shima K, et al. Nociceptive and nonnociceptive responses of neurons in the medial subthalamic region and lateral hypothalamic area of cats and their relationship to the effects of morphine and pentazocine. Tohoku J Exp Med 1982; 137: 11-19
18. Parent A. Carpenter's Human Neuroanatomy, Baltimore, MD: Williams and Wilkins, 1996
19. Paxinos G, Watson C. The Rat Brain in Stereotaxic Coordinates, San Diego, CA: Elsevier Academic Press, 2005
20. Pesenti A, Priori A, Locatelli M, et al. Subthalamic somatosensory evoked potentials in Parkinson's disease. Mov Disord 2003; 18: 1341-1345
21. Porter RH, Greene JG, Higgins DS, et al. Polysynaptic regulation of glutamate receptors and mitochondrial enzyme activities in the basal ganglia of rats with unilateral dopamine depletion. J Neurosci 1994; 14: 7192-7199
22. Reyes SS, Mitrofanis J. Fos expression in the spinal cord and periaqueductal grey matter in 6OHDA-lesioned rats. Int J Neurosci 2007; to be published
23. Rodriguez-Oroz MC, Rodriguez M, Guridi J, et al. The subthalamic nucleus in Parkinson's disease: Somatotopic organization and physiological characteristics. Brain 2001; 124: 1777-1790
24. Salin P, Manrique C, Forni C, et al. High-frequency stimulation of the subthalamic nucleus selectively reverses dopamine denervation-induced cellular defects in the output structures of the basal ganglia in the rat. J Neurosci 2002; 22: 5137-5148
25. Sandyk R. Sensory symptoms in Parkinson's disease. Pain 2006; 25: 139-140
26. Schober A. Classic toxin-induced animal models of Parkinson's disease: 6-OHDA and MPTP. Cell Tiss Res 2004; 318: 215-224
27. Stein WM, Read S. Chronic pain in the setting of Parkinson's disease and depression. J Pain Symptom Manage 1997; 14: 255-258
28. Svenningsson P, Le Moine C. Dopamine D1/5 receptor stimulation induces c-fos expression in the subthalamic nucleus: Possible involvement of local D5 receptors. Eur J Neurosci 2002; 15: 133-142
29. Tinazzi M, Del Vesco C, Fincati E, et al. Pain and motor complications in Parkinson's disease. J Neurol Neurosurg Psychiatry 2006; 77: 822-825